Apellis Pharmaceuticals Inc at Robert W Baird Global Healthcare Conference Transcript
All right. Good afternoon, everyone. Thanks for being with us for Baird's Global Healthcare Conference. I'm Colleen Kusy, one of the senior analysts covering biotech at Baird. It is my pleasure to have with us Apellis Pharmaceuticals CEO and Co-Founder, Cedric Francois, and CFO, Tim Sullivan. Thanks for being with us, guys. So Cedric, I'll turn it off to you to give some opening remarks.
Well, thank you, Colleen. Thank you for inviting us. I'm very happy to be back again. So yes, it was a very busy summer for us, of course, and a very intense year, lots of emotions. I'm going to start off with what really stood out this summer for us and that's the fact that we got the updated data on SYFOVRE, where we continue to see increasing effects over time with slowdowns as much as 45% between month 24 and 30. That means that if you are a patient with geographic atrophy, who
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
